Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world prevention and treatment study of spleen aminopeptide oral solution for seasonal allergic rhinitis in Hohhot
ChiCTR2400081563Phase 4Completed
- Sponsor
- Beijing Shijitan Hospital
- Start
- Mar 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of spleen polypeptide in seasonal allergic rhinitis (SAR) (2 arms), sponsored by Beijing Shijitan Hospital. Primary endpoint: Symptom score - four-point method. Started Mar 2024; status: completed.
02
Drugs
spleen polypeptide
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on ChiCTR2400081563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081563.